JENNIFER STRIMPLE: Open Payments
NPI 1073392635 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $389 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 2 | $248 |
| Madrigal Pharmaceuticals | 4 | $79 |
| Janssen Biotech, Inc. | 3 | $59 |
| GENZYME CORPORATION | 2 | $45 |
| Antares Pharma, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: IQIRVO, REZDIFFRA, TREMFYA, DUPIXENT, XYOSTED, EOHILIA.
Industry payments across TX — which companies pay providers there.
